PriceTargets.com logo

8X8 - EGHT Stock Price Target and Predictions

  • Consensus Rating: Reduce
  • Consensus Price Target: $2.49
  • Forecasted Upside: 22.45%
  • Number of Analysts: 8
  • Breakdown:
  • 4 Sell Ratings
  • 1 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$2.03 As of 12/4/2025 05:00 PM ET
▼ -0.01 (-0.49%)

This chart shows the closing price for EGHT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New 8X8 Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for EGHT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for EGHT

Analyst Price Target is $2.49
▲ +22.45% Upside Potential
This price target is based on 8 analysts offering 12 month price targets for 8X8 in the last 3 months. The average price target is $2.49, with a high forecast of $3.50 and a low forecast of $1.50. The average price target represents a 22.45% upside from the last price of $2.03.

This chart shows the closing price for EGHT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Reduce

The current consensus among 8 investment analysts is to reduce stock in 8X8. This rating has held steady since January 2025, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
6/12/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 2 sell ratings
Ratings as of
9/10/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 2 sell ratings
Ratings as of
12/9/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 4 sell ratings
Ratings as of
3/9/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 4 sell ratings
Ratings as of
6/7/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 4 sell ratings
Ratings as of
9/5/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 4 sell ratings
Ratings as of
11/4/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 4 sell ratings
Ratings as of
12/4/2025

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 4 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/1/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
11/25/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
11/19/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
11/13/2025Weiss RatingsReiterated RatingSell (E+) ➝ Sell (E+)
11/5/2025Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$2.50
10/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
9/13/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
8/30/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
8/29/2025Morgan StanleySet Target$1.90
8/21/2025Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$2.50
8/14/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
8/6/2025Rosenblatt SecuritiesLower TargetBuy ➝ Buy$2.70 ➝ $2.50
7/29/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
7/12/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
6/27/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
6/11/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
5/24/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
5/20/2025Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$2.70 ➝ $2.70
5/14/2025B. RileyReiterated RatingBuy ➝ Buy$4.00 ➝ $3.00
5/10/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
4/24/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
4/24/2025Rosenblatt SecuritiesLower TargetBuy ➝ Buy$3.30 ➝ $2.70
4/22/2025Wells Fargo & CompanyLower TargetUnderweight ➝ Underweight$2.00 ➝ $1.50
4/16/2025Morgan StanleyLower TargetUnderweight ➝ Underweight$2.60 ➝ $1.90
4/15/2025MizuhoLower TargetUnderperform ➝ Underperform$2.50 ➝ $2.00
4/8/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
3/22/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
3/7/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
2/19/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
2/5/2025Needham & Company LLCBoost TargetBuy ➝ Buy$3.00 ➝ $3.50
2/5/2025BarclaysBoost TargetEqual Weight ➝ Equal Weight$2.50 ➝ $3.00
2/3/2025Rosenblatt SecuritiesLower TargetBuy ➝ Buy$3.50 ➝ $3.30
2/1/2025Weiss RatingsReiterated RatingSell (D-) ➝ Sell (D-)
1/18/2025Weiss RatingsReiterated RatingSell (D-)
12/18/2024Morgan StanleyBoost TargetUnderweight ➝ Underweight$2.00 ➝ $2.60
12/13/2024MizuhoDowngradeNeutral ➝ Underperform$2.75 ➝ $2.50
11/5/2024MizuhoBoost TargetNeutral ➝ Neutral$2.50 ➝ $2.75
11/5/2024Wells Fargo & CompanyBoost TargetUnderweight ➝ Underweight$1.50 ➝ $2.00
11/5/2024BarclaysBoost TargetEqual Weight ➝ Equal Weight$2.00 ➝ $2.50
10/28/2024Rosenblatt SecuritiesLower TargetBuy ➝ Buy$4.00 ➝ $3.50
10/24/2024B. RileyReiterated RatingBuy ➝ Buy$7.00 ➝ $4.00
10/17/2024WedbushUpgradeHold
8/22/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$4.00 ➝ $4.00
8/9/2024BarclaysLower TargetEqual Weight ➝ Equal Weight$3.00 ➝ $2.00
8/9/2024Needham & Company LLCLower TargetBuy ➝ Buy$3.50 ➝ $3.00
8/7/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$4.00 ➝ $4.00
6/21/2024Wells Fargo & CompanyLower TargetUnderweight ➝ Underweight$2.00 ➝ $1.50
6/14/2024Morgan StanleyDowngradeEqual Weight ➝ Underweight$3.00 ➝ $2.00
5/20/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$3.50
5/9/2024Needham & Company LLCLower TargetBuy ➝ Buy$5.00 ➝ $3.50
4/17/2024Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$3.80 ➝ $3.00
3/18/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$4.00
2/1/2024Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$4.00
2/1/2024Needham & Company LLCReiterated RatingBuy ➝ Buy$5.00
1/18/2024Rosenblatt SecuritiesLower TargetBuy ➝ Buy$4.50 ➝ $4.00
11/2/2023Needham & Company LLCLower TargetBuy ➝ Buy$6.00 ➝ $5.00
11/2/2023BarclaysLower TargetEqual Weight ➝ Equal Weight$4.00 ➝ $2.50
11/2/2023Craig HallumUpgradeHold ➝ Buy$4.50
10/19/2023Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$4.00 ➝ $3.30
9/20/2023Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$5.00
8/28/2023Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$5.00
8/14/2023MizuhoLower TargetNeutral ➝ Neutral$5.00 ➝ $3.75
8/10/2023Needham & Company LLCLower TargetBuy ➝ Buy$7.00 ➝ $6.00
8/9/2023Rosenblatt SecuritiesLower TargetBuy ➝ Buy$6.00 ➝ $5.00
8/9/2023Craig HallumDowngradeBuy ➝ Hold$7.00 ➝ $4.00
8/3/2023Rosenblatt SecuritiesReiterated RatingBuy ➝ Buy$6.00
5/12/2023Wells Fargo & CompanyLower Target$4.50 ➝ $3.00
5/12/2023BarclaysLower Target$5.00 ➝ $4.00
3/23/2023Rosenblatt SecuritiesInitiated CoverageBuy$6.00
2/2/2023Roth CapitalReiterated RatingNeutral
2/2/2023Wells Fargo & CompanyBoost TargetUnderweight$4.00 ➝ $4.50
2/2/2023Needham & Company LLCBoost TargetBuy$6.00 ➝ $7.00
2/2/2023Morgan StanleyBoost TargetEqual Weight$4.50 ➝ $5.40
12/14/2022Morgan StanleyBoost TargetEqual Weight$4.00 ➝ $4.50
12/14/2022WedbushInitiated CoverageNeutral$7.00
11/1/2022Northland SecuritiesLower Target$8.00
10/28/2022Needham & Company LLCLower TargetBuy$8.00 ➝ $6.00
10/28/2022Wells Fargo & CompanyLower TargetUnderweight$5.00 ➝ $4.00
10/28/2022BarclaysLower TargetEqual Weight$5.00 ➝ $4.00
10/28/2022MizuhoLower TargetNeutral$6.00 ➝ $5.00
10/11/2022Morgan StanleyLower TargetEqual Weight$6.50 ➝ $4.00
8/8/2022Bank of AmericaUpgradeNeutral ➝ Buy
8/5/2022Craig HallumUpgradeHold ➝ Buy
8/5/2022OppenheimerDowngradeOutperform ➝ Market Perform
8/4/2022MKM PartnersInitiated CoverageNeutral$5.50
7/29/2022B. RileyLower Target$13.50 ➝ $10.00
7/28/2022William BlairReiterated RatingOutperform
7/28/2022Bank of AmericaLower TargetNeutral$10.00 ➝ $7.00
7/28/2022Needham & Company LLCLower TargetBuy$13.00 ➝ $8.00
7/28/2022Wells Fargo & CompanyLower TargetUnderweight$8.00 ➝ $5.00
7/28/2022BTIG ResearchDowngradeBuy ➝ Neutral
7/25/2022BarclaysLower TargetEqual Weight$10.00 ➝ $6.00
7/14/2022Morgan StanleyLower TargetEqual Weight$11.00 ➝ $6.50
6/24/2022Evercore ISIReiterated RatingOutperform ➝ Neutral$6.00
5/11/2022Needham & Company LLCLower Target$22.00 ➝ $13.00
5/11/2022Craig HallumLower Target$20.00 ➝ $10.00
5/11/2022Evercore ISILower Target$30.00 ➝ $18.00
5/11/2022BTIG ResearchLower Target$36.00 ➝ $16.00
5/11/2022MizuhoLower Target$15.00 ➝ $10.00
5/11/2022B. RileyUpgradeNeutral ➝ Buy$13.50
4/26/2022BarclaysLower TargetEqual Weight$17.00 ➝ $10.00
3/15/2022Wells Fargo & CompanyLower TargetUnderweight$15.00 ➝ $11.00
2/22/2022Morgan StanleyLower TargetEqual Weight$18.00 ➝ $16.00
2/3/2022Craig HallumLower Target$25.00 ➝ $20.00
2/3/2022B. RileyLower Target$19.00 ➝ $17.50
2/3/2022Needham & Company LLCLower TargetBuy$32.00 ➝ $22.00
1/28/2022Bank of AmericaInitiated CoverageBuy ➝ Buy$18.00
1/28/2022MizuhoLower Target$20.00 ➝ $15.00
1/26/2022Wells Fargo & CompanyLower TargetUnderweight$17.00 ➝ $15.00
1/24/2022BarclaysLower TargetEqual Weight$25.00 ➝ $17.00
1/12/2022Robert W. BairdDowngradeOutperform ➝ Neutral$32.00 ➝ $18.00
12/13/2021Wells Fargo & CompanyLower TargetUnderweight$20.00 ➝ $17.00
12/2/2021Craig HallumLower TargetHold$30.00 ➝ $25.00
12/2/2021B. RileyLower TargetNeutral$25.00 ➝ $19.00
11/3/2021B. RileyReiterated RatingNeutral
11/3/2021Needham & Company LLCReiterated RatingBuy$32.00
10/20/2021BarclaysInitiated CoverageEqual Weight$25.00
9/1/2021Colliers SecuritiesReiterated RatingBuy$42.00
8/5/2021Colliers SecuritiesReiterated RatingBuy$42.00
7/26/2021Colliers SecuritiesReiterated RatingBuy$42.00
6/21/2021Needham & Company LLCInitiated CoverageBuy$32.00
5/17/2021Craig HallumReiterated RatingBuy ➝ Hold
5/14/2021Morgan StanleyLower TargetEqual Weight$35.00 ➝ $30.00
5/13/2021Evercore ISIReiterated RatingBuy
5/11/2021B. RileyReiterated RatingNeutral$32.50 ➝ $25.00
5/11/2021Craig HallumDowngradeBuy ➝ Hold
4/20/2021Bank of AmericaInitiated CoverageNeutral$39.00
1/29/2021Craig HallumBoost TargetBuy$22.00 ➝ $45.00
1/25/2021Rosenblatt SecuritiesBoost TargetNeutral$18.00 ➝ $35.00
1/25/2021B. RileyBoost TargetNeutral$25.00 ➝ $32.50
1/21/2021Morgan StanleyBoost TargetEqual Weight$33.00 ➝ $35.00
1/19/2021BTIG ResearchBoost TargetBuy$35.00 ➝ $44.00
1/5/2021Wells Fargo & CompanyDowngradeEqual Weight ➝ Underweight$17.00 ➝ $25.00
12/23/2020Needham & Company LLCBoost TargetBuy$35.00 ➝ $40.00
12/17/2020Northland SecuritiesReiterated RatingBuy$23.00 ➝ $36.00
12/16/2020MizuhoBoost TargetNeutral$17.00 ➝ $25.00
12/11/2020Needham & Company LLCBoost TargetBuy$21.00 ➝ $35.00
12/11/2020B. RileyBoost TargetNeutral$15.25 ➝ $25.00
(Data available from 12/4/2020 forward)

News Sentiment Rating

0.67 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 11 very positive mentions
  • 7 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
5/8/2025
  • 15 very positive mentions
  • 18 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
6/7/2025
  • 8 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/7/2025
  • 4 very positive mentions
  • 11 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
8/6/2025
  • 11 very positive mentions
  • 19 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
9/5/2025
  • 8 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
10/5/2025
  • 0 very positive mentions
  • 5 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/4/2025
  • 13 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
12/4/2025

Current Sentiment

  • 13 very positive mentions
  • 15 positive mentions
  • 2 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

8X8 logo
8x8, Inc. engages in the provision of enterprise communication solutions. It offers solutions to the business services, education, financial services, government, healthcare, and manufacturing industries. The company was founded in February 1987 and is headquartered in Campbell, CA.
Read More

Today's Range

Now: $2.03
Low: $2.01
High: $2.07

50 Day Range

MA: $1.95
Low: $1.77
High: $2.27

52 Week Range

Now: $2.03
Low: $1.52
High: $3.52

Volume

413,159 shs

Average Volume

588,783 shs

Market Capitalization

$281.44 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.95

Frequently Asked Questions

What sell-side analysts currently cover shares of 8X8?

The following sell-side analysts have issued reports on 8X8 in the last twelve months: B. Riley, Barclays PLC, Mizuho, Morgan Stanley, Needham & Company LLC, Rosenblatt Securities, Wall Street Zen, Weiss Ratings, and Wells Fargo & Company.
View the latest analyst ratings for EGHT.

What is the current price target for 8X8?

0 Wall Street analysts have set twelve-month price targets for 8X8 in the last year. Their average twelve-month price target is $2.49, suggesting a possible upside of 22.1%. Needham & Company LLC has the highest price target set, predicting EGHT will reach $3.50 in the next twelve months. Wells Fargo & Company has the lowest price target set, forecasting a price of $1.50 for 8X8 in the next year.
View the latest price targets for EGHT.

What is the current consensus analyst rating for 8X8?

8X8 currently has 4 sell ratings, 1 hold rating and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Reduce."
View the latest ratings for EGHT.

What other companies compete with 8X8?

Other companies that are similar to 8X8 include Upbound Group, Yext, TaskUs, Criteo and Radware. Learn More about companies similar to 8X8.

How do I contact 8X8's investor relations team?

8X8's physical mailing address is 675 Creekside Way, Campbell CA, 95008. The company's listed phone number is (408) 727-1885 and its investor relations email address is [email protected]. The official website for 8X8 is www.8x8.com. Learn More about contacing 8X8 investor relations.